logo

Spark Therapeutics (ONCE)



Trade ONCE now with
  Date
  Headline
5/9/2018 9:40:38 AM Wedbush Reiterates Spark Therapeutics (ONCE) At Underperform With $40 Price Target
5/8/2018 7:36:11 AM Spark Therapeutics Q1 Net Loss Applicable To Common Stockholders $46.4 Mln Or $1.25/Shr
4/30/2018 7:31:53 AM Spark Therapeutics Sells Priority Review Voucher For $110 Mln
2/21/2018 7:56:12 AM Wedbush Is Increasing Spark Therapeutics (ONCE) FY18 Rev. Estimate To 239.5 M From 213.3 M
2/21/2018 7:55:48 AM Wedbush Is Raising Spark Therapeutics (ONCE) Q3 18 Rev. Estimate To 48.1 M From 41.1 M
2/21/2018 7:55:37 AM Wedbush Is Raising Spark Therapeutics (ONCE) Q2 18 Rev. Estimate To 150.4 M From 140.8 M
2/21/2018 7:55:26 AM Wedbush Is Raising Spark Therapeutics (ONCE) Q1 18 Rev. Estimate To 24.6 M From 15.0 M
2/21/2018 7:55:04 AM Wedbush Is Increasing Spark Therapeutics (ONCE) FY19 Estimate To -1.76 From -2.30
2/21/2018 7:54:33 AM Wedbush Is Cutting Spark Therapeutics (ONCE) Q4 18 Estimate To -1.53 From -1.51
2/21/2018 7:54:18 AM Wedbush Is Increasing Spark Therapeutics (ONCE) Q3 18 Estimate To -0.66 From -0.82
2/21/2018 7:54:08 AM Wedbush Is Raising Spark Therapeutics (ONCE) Q2 18 Estimate To 1.68 From 1.50
2/21/2018 7:53:46 AM Wedbush Is Raising Spark Therapeutics (ONCE) Q1 18 Estimate To -1.25 From -1.47
2/20/2018 7:36:09 AM Spark Therapeutics FY Net Loss $253.5 Mln Or $7.63/Shr Vs Loss Of $123.7 Mln Or $4.29/Shr Last Year
2/8/2018 9:06:22 AM RBC Capital Markets Is Lowering Spark Therapeutics (ONCE) FY19 Rev. Estimate To 70.5 M From 99.6 M
2/8/2018 9:06:09 AM RBC Capital Markets Is Increasing Spark Therapeutics (ONCE) FY18 Rev. Estimate To 162.2 M From 42.3 M
2/8/2018 9:05:56 AM RBC Capital Markets Is Cutting Spark Therapeutics (ONCE) Q4 18 Rev. Estimate To 14.3 M From 22.9 M
2/8/2018 9:05:44 AM RBC Capital Markets Is Increasing Spark Therapeutics (ONCE) Q3 18 Rev. Estimate To 34.3 M From 10.8 M
2/8/2018 9:05:26 AM RBC Capital Markets Is Increasing Spark Therapeutics (ONCE) Q1 18 Rev. Estimate To 108.3 M From 3.3 M
  
 
>